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14-3-3ζ Role in Promoting Survival of Cells to Facilitate Progression of Cancer
Katherine McCormack, Katie Pennington, Eranga Roshan, Joshua Andersen
Department of Chemistry and Biochemistry, Brigham Young University, Provo, Utah 84602
Introduction

Objective

Cancer is the rapid growth of abnormal cells. It is caused by the
accumulation of mutations that drive growth and survival. The
upregulation of these progrowth and prosurvival genes aids in the
proliferation and metastasis of cancer cells.

Find and characterize interactors of 14-3-3ζ that can then be targeted
by novel chemotherapy treatments in order to combat chemoresistance.

For this study, we chose to study the hub protein 14-3-3ζ. 14-3-3ζ is
upregulated in a myriad of cancer types1. High expression levels of 143-3ζ are associated with the development of chemoresistance to
previously effective treatment (Table 1). 14-3-3ζ contributes to
proliferation and survival pathways that aid in tumor development and
progression by binding phosphorylated proteins.

Methods
To assess changes in the 14-3-3ζ interactome during hypoxia, we
performed co-immunoprecipitation experiments to pull-down 14-3-3ζ
along with all of the proteins bound by 14-3-3ζ from cells either
exposed to hypoxic conditions for 6 hours prior to harvesting or
maintained in normal growth conditions. We then used LC-MS/MS to
identify the proteins pulled down by 14-3-3ζ under the two conditions.

From this data, we focused on TAK1 and TAB2 because they are
known to function together in the pro-survival/ pro-proliferation NFκB pathway3. TAK1 is known to interact with 14-3-3ζ in response to
DNA damage, but neither protein has been reported to interact with
14-3-3ζ in hypoxia. This data potentially illustrates a previously
unknown node of 14-3-3ζ regulation in the NF-κB pathway.
After identifying TAK1 and TAB2 as likely 14-3-3ζ interactors, we
needed to validated that the 14-3-3ζ interaction observed in the MS
experiment was replicable using a more targeted method. We did this
by preforming a co-immunoprecipitation and Western blot using cells
exposed to different durations of hypoxia (Figure 2).

From the list of interacting proteins identified in our MS studies, we
selected two interactors for further validation: TAB2 and TAK1. We
repeated the hypoxia experiment at multiple durations of hypoxia,
pulled down 14-3-3ζ co-immunoprecipitates, and performed Western
blots to validate the hypoxia-specific 14-3-3ζ/TAB2 and interactions.

Figure 1. 3-D X-ray crystal structure of the protein 14-3-3ζ.

Under normal growth conditions, the interactome of 14-3-3ζ is well
understood. However, the interactome of 14-3-3ζ changes with cellular
stresses to promote appropriate stress responses2. We are interested in
the 14-3-3ζ interactome during hypoxic stress due to the prevalence of
hypoxia in solid tumors. Hypoxia results from insufficient blood
supply to the rapidly proliferating tumor, resulting in portions of the
tumor having low oxygen and nutrient levels. Prosurvival adaptations
specific to stresses such as hypoxia are advantageous to the survival of
tumor cells.

The unknown proteins identified as likely 14-3-3ζ interactors
Gene

Description

Counts

RABEP1

Rab GTPase-binding effector protein 1

5

TAB2

TGF-beta-activated kinase 1 and MAP3K7-binding protein 2

3

RBM26

RNA-binding protein 26

3

U2AF2

Splicing factor U2AF 65 kDa subunit

3

MAP3K7

Mitogen-activated protein kinase kinase kinase 7 (TAK1)

2

SLTM

SAFB-like transcription modulator

2

SCLT1

Sodium channel and clathrin linker 1

2

SRBD1

S1 RNA-binding domain-containing protein 1

2

SPATA16

Spermatogenesis-associated protein 16

2

CCDC8

Coiled-coil domain-containing protein 8

2

HARS

Histidine--tRNA ligase cytoplasmic

2

Table 2. Protein MS counts for all samples with >1 count for hypoxia and 0
counts for mock, WT normoxia, K49E normoxia, and K49E hypoxia.
Table 1. 14-3-3ζ expression in common cancer types.
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Conclusions
The research we have done thus far allowed us to identify specific
interactors of 14-3-3ζ under hypoxic stress. We then confirmed that
the 14-3-3ζ/TAB2 and 14-3-3ζ/TAK1 interactions were induced by
hypoxia. Therefore, we hypothesize that the TAB2 and TAK1
interaction with 14-3-3ζ may promote the NF-κB pathways under
hypoxic conditions.

Future Direction

Results
Our protein MS experiments identified novel interactors. Table 2
shows a list of hypoxia-specific interacting proteins.

In this experiment, we also observed that the induction of TAK1 and
TAB2 binding to 14-3-3ζ occurred with similar timing and stability
relative to each other. This leads us to hypothesize that the
phosphorylations responsible for 14-3-3ζ binding to TAB2 and TAK1
are likely mediated by the same hypoxia-responsive kinase.
Alternatively, one of the proteins (i.e. TAK1) may be bridging the
interaction between 14-3-3ζ and the other protein (i.e. TAB2).
Experiments are ongoing to test these hypotheses

Figure 2. Western blot of co-immunoprecipitation of 14-3-3z blotting for TAB2
and TAK1.

Our research is now focused on the effect(s) of the interactions during
hypoxic stress, such as whether 14-3-3ζ binding to TAB2 and TAK1
promotes activation of the NF-κB pathway, and whether they influence
changes in motility, angiogenesis, and/or metastasis. We are also
working to characterize this pathway by identifying the kinase(s),
phosphatase(s), and other proteins that effect 14-3-3ζ involvement in
this pathway.

After one hour of hypoxia, the interactions between 14-3-3ζ and both
TAK1 and TAB2 are increased dramatically and stays consistent over
the time course of the experiment. This shows that the 14-3-3ζ
interaction with both TAK1 and TAB2 is induced quickly and is stable
under continued hypoxic stress.
We ensured that hypoxia was inducing the interaction by comparing
the pull-down intensity for hypoxia with that for normoxia and the
mock-transfected controls, which were cells that did not express the
tagged 14-3-3ζ used for the immunoprecipitation. Because the bands
corresponding to the TAB2 and TAK1 protein were much less intense
for both the normoxia and mock samples than for the hypoxia time
course samples, we can say that hypoxia was inducing interaction.
To assess whether the increased binding of TAB2 and TAK1 could be
attributable to increased levels of TAB2 or TAK1 protein within the
cells, we blotted the lysate for both TAB2 and TAK1 and did not
observe any appreciable differences among the samples. This shows
that increases in TAK1 and TAB2 protein levels were not responsible
for the increased pull-down.

Figure 3. Possible pathway for the interaction of the proposed 14-3-3ζ and
TAB2 and TAK1 complex in the NF-κB pathway under hypoxia.
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